We are assessing a new therapy using tumor-infiltrating lymphocytes for cancer patients. The goal is to evaluate how safe and tolerable this treatment is.
Health conditions and diseases that the clinical trial is designed to study and treat.
Malignant solid tumors are cancerous growths that can develop in various tissues of the body, often leading to serious health issues. Advanced epithelial tumors that are resistant to immune checkpoint blockade therapies pose significant treatment challenges.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.